Griffiths Rhianna, Lim Steve, Lin Julian, Bates Andrew, Jones Liam, Ibrahim Kinda
Faculty of Medicine, University of Southampton, Southampton, UK.
NIHR Applied Research Collaboration Wessex, University of Southampton, Southampton, UK.
Basic Clin Pharmacol Toxicol. 2025 Oct;137(4):e70103. doi: 10.1111/bcpt.70103.
BACKGROUND: Anticholinergic medication use is increasing, particularly among older adults due to polypharmacy and comorbidities. High anticholinergic burden is linked to adverse outcomes such as reduced mobility and increased dementia risk. Acute hospital stays may offer an opportunity to address this often-overlooked issue. AIMS: To examine the effects of deprescribing anticholinergic medications on outcomes in older hospitalised patients. METHODS: Medline, Web of Science, Cochrane Library and Embase were searched from inception to September 2024. Studies included hospital-based deprescribing or medication review interventions targeting anticholinergic burden in patients aged ≥ 65 years. Narrative synthesis followed SWiM guidelines, with quality assessment using JBI Checklists. RESULTS: From 2042 records, eight studies met inclusion criteria. Designs included cohort (n = 4) and pre-post quasi-experimental (n = 4), with follow-up durations of up to 3 months. All reported medication-related outcomes; four assessed acceptability, one included clinical outcomes, and none examined safety. Six studies reported reductions in anticholinergic burden scores; three showed significant decreases in the proportion of patients prescribed anticholinergics, and two noted fewer potentially inappropriate medications. Most recommended changes were implemented. CONCLUSION: Deprescribing interventions in hospital appear acceptable and effective in reducing anticholinergic burden. However, evidence on clinical outcomes, costs and safety is limited. Further RCTs with longer follow-up are needed.
背景:抗胆碱能药物的使用正在增加,尤其是在老年人中,这是由于多重用药和合并症所致。高抗胆碱能负担与诸如活动能力下降和痴呆风险增加等不良后果相关。急性住院期间可能提供了一个解决这个经常被忽视问题的机会。 目的:研究停用抗胆碱能药物对老年住院患者预后的影响。 方法:检索了从数据库建库至2024年9月的Medline、科学网、考克兰图书馆和Embase。纳入的研究包括针对65岁及以上患者抗胆碱能负担的基于医院的减药或药物审查干预措施。采用SWiM指南进行叙述性综合分析,并使用JBI清单进行质量评估。 结果:从2042条记录中,有8项研究符合纳入标准。研究设计包括队列研究(n = 4)和前后对照准实验研究(n = 4),随访时间长达3个月。所有研究均报告了与药物相关的结局;4项评估了可接受性,1项纳入了临床结局,没有研究考察安全性。6项研究报告抗胆碱能负担评分降低;3项研究显示开具抗胆碱能药物的患者比例显著下降,2项研究指出潜在不适当用药减少。大多数推荐的更改都得到了实施。 结论:医院中的减药干预措施似乎在降低抗胆碱能负担方面是可接受且有效的。然而,关于临床结局、成本和安全性的证据有限。需要进行更长随访期的进一步随机对照试验。
Basic Clin Pharmacol Toxicol. 2025-10
Cochrane Database Syst Rev. 2022-8-22
JAMA Netw Open. 2025-5-1
Cochrane Database Syst Rev. 2013-8-21
Cochrane Database Syst Rev. 2012-12-12
Cochrane Database Syst Rev. 2017-3-16
Int J Environ Res Public Health. 2023-3-30
Br J Clin Pharmacol. 2022-3
Int J Clin Pharm. 2021-12